Florida Argues ‘Unproven’ Transgender Care Barred From Medicaid

Current medical consensus supports the conclusion that gender dysphoria treatments are experimental and can be excluded from Medicaid coverage, Florida’s health-care agency told a federal court.

The Florida Agency for Health Care Administration and Secretary Jason Weida, which administer the state’s Medicaid program, have asked the US District Court for the Northern District of Florida for summary judgment in a suit brought by Medicaid-eligible transgender patients. The patients are trying to secure payment for medications and procedures the agency excluded from coverage in August 2022, including puberty blockers, hormone therapy, and gender-affirming surgeries.

This is one of several cases challenging ...